CIK 0001526119 · Non-accelerated filer<br>Smaller reporting company
Verastem, Inc.
Sign in to watch- Ticker
- VSTM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- EIN
- 273269467
- Phone
- (781) 292-4200
- Business address
- 117 KENDRICK STREET, SUITE 500, NEEDHAM, MA, 02494
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $386,390
- in 4 filings, $386K under 10b5-1 plans
Net −$386,390. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-15 | JOHNSON JOHN Director | Grant or award · Stock Option (right to buy) | +62,500 | 62,500 | ||
| 2023-05-15 | Gagnon Robert E. Director | Grant or award · Stock Option (right to buy) | +62,500 | 62,500 | ||
| 2023-05-15 | ROBERTSON MICHELLE Director | Grant or award · Stock Option (right to buy) | +62,500 | 62,500 | ||
| 2023-05-15 | Tollefson Karin Anna Director | Grant or award · Stock Option (right to buy) | +187,500 | 187,500 | ||
| 2023-04-05 | Calkins Daniel Vice President of Finance | Sale | −75 | $0.37 | $28 | 101,397 |
| 2023-03-24 | Calkins Daniel Vice President of Finance | Sale | −378 | $0.42 | $159 | 101,472 |
| 2023-03-20 | Gagnon Robert E. Director | Sale | −1,664 | $0.43 | $716 | 569,399 |
| 2023-03-20 | Paterson Dan President and COO | Sale | −2,339 | $0.43 | $1K | 458,351 |
| 2023-03-20 | Stuglik Brian M Chief Executive Officer | Sale | −3,508 | $0.43 | $2K | 1,112,736 |
| 2023-03-16 | Gagnon Robert E. Director | Sale | −3,654 | $0.40 | $1K | 571,063 |
| 2023-03-16 | Paterson Dan President and COO | Sale | −3,138 | $0.40 | $1K | 460,690 |
| 2023-03-16 | Stuglik Brian M Chief Executive Officer | Sale | −6,276 | $0.40 | $3K | 1,116,244 |
| 2023-01-27 | Stuglik Brian M Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +2,216,355 | 2,216,355 | ||
| 2023-01-27 | Paterson Dan President and COO | Grant or award · Stock Option (Right to Buy) | +1,680,880 | 1,680,880 | ||
| 2023-01-27 | Calkins Daniel Vice President of Finance | Grant or award · Stock Option (Right to Buy) | +165,000 | 165,000 | ||
| 2023-01-05 | Calkins Daniel Vice President of Finance | Sale | −74 | $0.43 | $32 | 98,517 |
| 2022-12-27 | Calkins Daniel Vice President of Finance | Sale | −1,246 | $0.33 | $411 | 98,591 |
| 2022-12-19 | Paterson Dan President and COO | Sale | −2,954 | $0.37 | $1K | 463,828 |
| 2022-12-19 | Gagnon Robert E. Director | Sale | −1,429 | $0.37 | $529 | 574,717 |
| 2022-12-19 | Stuglik Brian M Chief Executive Officer | Sale | −3,556 | $0.37 | $1K | 1,122,520 |
Page 13 of 17 · 326 trades